ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C08DB01 | B | Diltiazem HCl - 300mg | 3045 | 27057 | MONO-TILDIEM LP/SR | 300mg | 28 | Capsule, sustained release | Oral | Mersaco | Sanofi Winthrop Industrie | France | 470,135 L.L | 23.08 | A1 | 2/1/2023 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C08DB01 | B | Diltiazem HCl - 300mg | 3631 | 78726 | ADIZEM XL | 300mg | 28 | Capsule, sustained release | Oral | Mersaco | Bard Pharmaceuticals Ltd | UK | 559,053 L.L | 23.08 | A2 | Napp Pharmaceuticals Ltd | UK | 2/1/2023 | 0 |